Jun 11, 2020
Egle Therapeutics Enters Into a Corporate Strategic Research Alliance with Takeda to Uncover Novel Tumor-specific Regulatory T-cell Targets and Develop Unique Anti-Suppressor-Based Immunotherapies
Jun 11, 2020
Harbour BioMed Appoints Dr. Jon Wigginton to its Scientific Advisory Board
Jun 11, 2020
Kymera Therapeutics to Disclose IRAKIMiD Degrader Program and Present Preclinical Data Demonstrating Potent Immunomodulatory and Antitumor Activity for its Novel STAT3 Degraders in Immuno-oncology
Jun 11, 2020
Leap Therapeutics Announces Oprhan Drug Designation of DKN-01 for the Treatment of Gastric and Gastroesophageal Junction Cancer
Jun 11, 2020
Scopus BioPharma Licenses Novel Immuno-Oncology Gene Therapy Drug from City of Hope, a Cancer Center in Los Angeles, California
Jun 10, 2020
BryoLogyx Announces Agreements with Neurotrope to Acquire Bryostatin-1 Immuno-Oncology Data Package, Supply Synthetic Bryostatin-1
Jun 10, 2020
Curis Announces FDA Clearance of IND Application for CI-8993, the First-In-Class Monoclonal Anti-VISTA Antibody
Jun 10, 2020
Akadeum & NanoCellect Collaborating to Improve Rare-Cell Workflows and Results
Jun 10, 2020
Aptevo Therapeutics and Alligator Bioscience Present new Preclinical Data for ALG.APV-527 at the PEGS Virtual Interactive Global Summit
Jun 10, 2020
PharmAbcine execute an agreement with Thermo Fisher for the development and manufacturing of its next-generation immune checkpoint blockade, PMC-309 for Phase I
Jun 09, 2020
Sutro Biopharma to Present New Preclinical Data on its STRO-002 Antibody-Drug Conjugate at the Upcoming AACR 2020 Virtual Meeting on June 22, 2020
Jun 08, 2020
Phio Pharmaceuticals to Host Key Opinion Leader Call on Intratumoral Therapy with Self-Delivering RNAi on Friday, June 12th
Jun 08, 2020
Scientists Identify Targets for COVID-19 Vaccine Using Cancer Immunotherapy Tools
Jun 04, 2020
Targovax Enters Collaboration With Leidos to add Checkpoint Inhibitor Functionality to ONCOS Viruses
Jun 04, 2020
Apexigen Appoints Gordon Ringold to its Board of Directors
Jun 04, 2020
Oncolytics Biotech® Provides Recap of Key Opinion Leader Call Highlighting the Induction of Rapid and Persistent Immune Responses With Systemic Pelareorep Treatment
Jun 04, 2020
Alligator Bioscience and Scandion Oncology Sign Preclinical Agreement to Explore Combination Therapies for Chemotherapy and Immuno-oncology
Jun 04, 2020
TVAX Biomedical Receives Fast Track Designation from the FDA for Brain Cancer
Jun 03, 2020
Online Video Education Series from SITC and PlatformQ Health to Better Equip HCPs Managing Cancer Patients Undergoing Immunotherapy
Jun 02, 2020
FDA Clears IND for iNKT Cells to Treat COVID-19 Patients